← All organizations

ORION Sante

Academic/HospitalWebsite ↗

Also known as: Orion Biotechnology Polska Sp. z o.o.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jan 31, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 3 trials)

Phase 4 (1 own, 0 via acquisition)

imiquimod

Phase 1 (1 own, 0 via acquisition)

ob-002

Indications

Studied for

Warts

Recent trials (3)

NCT05940844Lead sponsorPhase 1Jan 31, 2024
NCT04791007Lead sponsorEarly Phase 1Oct 5, 2019
NCT00761371CollaboratorPhase 4Aug 1, 2002

Details

Last known activity: Jan 31, 2024